( NYSE:NVTA )

News from Invitae Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 05, 2017, 07:30 ET Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families

Research presented today by Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, shows how clinicians are...


Nov 15, 2017, 07:30 ET Invitae Completes Acquisition of CombiMatrix, Becoming a Leader in Family and Reproductive Health Genetic Information Services

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced it has completed its acquisition of...


Nov 08, 2017, 16:38 ET Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants

Invitae Corporation (NYSE: NVTA) one of the fastest growing genetic information companies, today issued a reminder to CombiMatrix...


Nov 06, 2017, 16:01 ET Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced financial and operating results for the...


Oct 30, 2017, 07:30 ET Invitae Presents Validation of a Novel NGS-based Preimplantation Genetic Screening Technology to Identify the Most Frequent Chromosomal Causes of Miscarriage

Invitae (NYSE: NVTA), one of the fastest growing genetic information companies, is presenting validation data for a novel, NGS-based...


Oct 24, 2017, 07:30 ET Invitae to announce third quarter 2017 Financial Results and Host Conference Call on November 6, 2017

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it will report its third quarter...


Oct 17, 2017, 07:30 ET Invitae data shows increased diagnosis rates with custom NGS technique allowing simultaneous genetic sequencing and copy number variant detection

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, is presenting data showing genetic sequencing and copy...


Oct 06, 2017, 07:30 ET Invitae Commences Exchange Offer for CombiMatrix Series F Warrants

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it has commenced an offer to...


Oct 05, 2017, 07:30 ET Invitae's new framework for classifying genetic variants aims to improve consistency of genetic test results industry-wide

As genetic testing grows both more complex and more integrated into mainstream medical care, continually improving how genetic variants are...


Sep 13, 2017, 07:35 ET Invitae highlighting new research, expanded suite of services at National Society of Genetic Counselors (NSGC) 36th Annual Conference

Researchers from Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, will present initial findings showing...


Sep 13, 2017, 07:30 ET Invitae to Present at the Cantor Fitzgerald Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Katherine Stueland, chief...


Aug 29, 2017, 07:30 ET Invitae to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive...


Aug 07, 2017, 16:05 ET Invitae Reports Second Quarter 2017 Results

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced financial and operating results for the...


Jul 31, 2017, 16:57 ET Invitae Acquiring Good Start Genetics and CombiMatrix, Adding Comprehensive Reproductive Health Capabilities to Serve Every Stage of Life

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced two acquisitions to establish a leading...


Jul 31, 2017, 16:54 ET Invitae Announces $73.5 Million Private Placement Offering to Fuel Strategic Growth Opportunities and Reports Preliminary Second Quarter Financial Results

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, has entered into a definitive agreement to sell $73.5...


Jul 24, 2017, 07:30 ET Invitae to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 7, 2017

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it will report its second quarter...


Jun 12, 2017, 07:30 ET Invitae Acquires CancerGene Connect, Award-Winning Risk Assessment and Family History Analysis Platform

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, has acquired Ommdom Inc., which develops healthcare...


Jun 05, 2017, 08:17 ET ASCO Data Shows Prostate Cancer Patients with Genetic Risk Factors Missed Under Current Testing Guidelines

A new analysis of genetic testing results among prostate cancer patients shows a substantial portion of patients with clinically significant...


Jun 01, 2017, 09:08 ET Invitae to present at the Goldman Sachs 38th Annual Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Randy Scott, executive chairman of...


May 25, 2017, 07:30 ET Invitae Broadens Management Team to Scale Expanding Business and Meet Rising Demand

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, announced that industry veteran Shelly Guyer, most...


May 12, 2017, 07:30 ET Invitae to Present at the UBS Global Healthcare Conference

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive...


May 08, 2017, 16:01 ET Invitae Exceeds 26,000 Samples Accessioned, Reports Revenue of $10.3 Million and Net Loss of $0.64 Per Share in First Quarter 2017

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced financial and operating results for the...


Apr 28, 2017, 07:30 ET New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing

New research suggests that current clinical guidelines on the use of genetic testing in breast cancer patients are too narrow and allow patients...


Apr 27, 2017, 07:30 ET Invitae to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that Sean George, chief executive...


Apr 24, 2017, 07:30 ET Invitae to Announce First Quarter 2017 Financial Results and Host Conference Call on May 8, 2017

Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced that it will report its first quarter...